Topics

Aimmune Presents New Peanut Allergy Data and Presses for Real-World Data Approaches

19:00 EST 7 Nov 2019 | BioSpace

AR101 is an investigational, peanut-derived, biologic drug candidate for oral immunotherapy in patients with peanut allergy. It delivers a daily dose of peanut protein with a consistent protein profile.

Original Article: Aimmune Presents New Peanut Allergy Data and Presses for Real-World Data Approaches

NEXT ARTICLE

More From BioPortfolio on "Aimmune Presents New Peanut Allergy Data and Presses for Real-World Data Approaches"

Quick Search

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...